Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500913 · ClinicalTrials.gov registry record
Adipose Tissue and Serum Inflammation in GH Deficiency
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 19
- Enrollment target
NCT03500913 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 19 participants.
The verdict
NCT03500913 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study will examine adipose tissue inflammation and adipokine expression and serum markers of inflammation and adipokine levels in patients with growth hormone (GH) deficiency before and after treatment.
Interventions
- DRUG Growth Hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-05-19 |
| Est. Completion | 2020-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500913
The ClinicalTrials.gov registry entry for NCT03500913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Growth Hormone is the first listed.
NCT03500913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500913 about?
NCT03500913 is a clinical study titled "Adipose Tissue and Serum Inflammation in GH Deficiency". This study will examine adipose tissue inflammation and adipokine expression and serum markers of inflammation and adipokine levels in patients with growth hormone (GH) deficiency before and after treatment.
What is the current status of trial NCT03500913?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2019-05-19. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03500913?
The interventions under investigation include: Growth Hormone (DRUG).
Who is sponsoring clinical trial NCT03500913?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.